DGAP-News Eckert & Ziegler Strahlen- und Medizintechnik AG: Fritz Oesterle reinforces Eckert & Ziegler Supervisory Board
0
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key
word(s): Change of Personnel/Miscellaneous
Eckert & Ziegler Strahlen- und Medizintechnik AG: Fritz Oesterle
reinforces Eckert & Ziegler Supervisory Board
14.12.2011 / 10:42
Berlin, 14 December 2011. The lawyer and long-term former CEO of
MDAX-listed Celesio AG, Dr. Fritz Oesterle (59), will reinforce the
Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG from
January 2012. He replaces the fund manager, Holger Bürk, who will lay down
his mandate as of 31 December 2011 after a three-year period of office as
the expectations associated with his entry into the Supervisory Board ´were
more than satisfied´. A direct exchange of both Supervisory Board members
is possible as according to the statutes the founders of Eckert & Ziegler
AG are entitled to delegate a member of the Supervisory Board.
´I would like to thank Mr Bürk for the trustworthy cooperation and his many
years of work. Due to his associations with the financial markets he was a
valuable supplement to our body, in particular following the turbulences on
the capital markets which began during the course of the Lehman-Brothers
crisis. I am now pleased with Dr. Oesterle to be able to welcome a
distinguished expert from the health sector. He will help us to continue to
press ahead with the orientation of Eckert & Ziegler AG to
radiopharmaceuticals which record strong growth´, Dr. Andreas Eckert, CEO
of Eckert & Ziegler AG, declared.
Dr. Fritz Oesterle is a lawyer and, inter alia, a member of the supervisory
board of Landesbank Baden-Wuerttemberg and of Schwarz Unternehmenstreuhand
(Kaufland, Lidl). He was previously CEO of Celesio AG for twelve years. Dr.
Oesterle is also a member of various bodies, to include the health
committee of the German Chamber of Commerce (DIHK), Berlin, the health
committee of the Economic Affairs Council [Wirtschaftsrat] Germany, and the
advisory board of Société Générale in Germany. Besides, Dr. Oesterle is the
British Honorary Consul in Baden-Wuerttemberg.
With around 580 employees the Eckert & Ziegler Group (ISIN DE0005659700) is
among the largest providers of isotope components for radiation therapy and
nuclear medicine worldwide.
If you have any questions please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de
End of Corporate News
14.12.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP´s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, Düsseldorf, Hamburg, München
End of News DGAP News-Service
149689 14.12.2011
Bewerten Sie diesen Artikel: (
0
Bewertungen)
